The encapsulation of metformin on chitosan matrix as diabetes mellitus drug slow release system

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This study was aimed to encapsulation metformin, the diabetes melittus type 2 drugs. In this study, chitosan-alginat and tween 80 composites were used as matrix encapsulation. The chitosan was mixed with variation of the composition of metformin-calcium alginate-tween 80. The effectivity of encapsulation was evaluated from surface morphology, functional group, % drug encapsulation efficiency and effect soaked on stability encapsulation. The metformin encapsulated was characterized to analysis of the functional group and particle size. The results showed that the metformin encapsulated a slightly rough surface with a good appearance. The drug encapsulation efficiency was about 7.06 to 30.32 %.

Cite

CITATION STYLE

APA

Cahyaningrum, S. E., Herdyastuti, N., Imroni, W., & Sholikhah, A. (2020). The encapsulation of metformin on chitosan matrix as diabetes mellitus drug slow release system. Rasayan Journal of Chemistry, 13(1), 389–394. https://doi.org/10.31788/RJC.2020.1315551

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free